Latham & Watkins advises banks in the refinancing of Biogroup

The leading private medical laboratory services company in France and Belgium has successfully completed a refinancing of its existing debt.

10/02/2021

Paris-based team represented lenders and initial purchasers in connection with refinancing of leading private medical laboratory group in France and Belgium.
Biogroup, the leading private medical laboratory services company in France and Belgium, has successfully completed a refinancing of its existing debt. The refinancing comprises a term loan B borrowed under a new senior facilities agreement, the issuance of €800 million in aggregate principal amount of 3.375% senior secured notes due 2028 and the issuance of €250 million in aggregate principal amount of 5.000% senior notes due 2029. The transaction represents the debut issuance of high yield notes by Biogroup.

The new senior facilities agreement consists of a term loan B in an aggregate principal amount of €1,450 million with a seven-year maturity and a revolving credit facility providing for borrowings up to a principal amount of up to €271 million with a 6.5 year maturity.
BNP Paribas, J.P. Morgan and Natixis acted as global active coordinators, mandated lead arrangers and Bookrunners, with several other financial institutions acting as mandated lead arrangers and bookrunners under the senior facilities agreement. In addition, J.P. Morgan acted as sole physical bookunner and J.P. Morgan, BNP Paribas and Natixis acted as global coordinators and joint bookrunners, with several other financial institutions acting as joint bookrunners with respect to the notes offerings.
Latham & Watkins represented the lenders and initial purchasers in the transaction, with a Paris-based team led by finance partner Lionel Dechmann and capital markets partner Thomas Margenet-Baudry, with finance associates Virginie Terzic, Matthieu Herviaux and Anas Benmalek, capital markets counsel Michael Ettannani and capital markets associate Laurie Tomassian.

 
 

Avertissement : Nous vous remercions de l’intérêt que vous portez à Latham & Watkins. Si vous souhaitez nous confier un dossier mais que vous n'êtes pas encore client du cabinet, merci de ne nous transmettre aucune information confidentielle. Nous ne pouvons pas accepter un dossier avant de nous être assurés que nous sommes en mesure de vous assister et d’avoir trouvé un accord avec vous sur les termes et conditions de notre intervention. Dans la mesure où nous n’aurons pas de relation avocat-client avec vous auparavant, nous n’aurons aucune obligation de confidentialité à l’égard des informations que vous nous auriez transmises. Merci de votre compréhension.